Современные подходы к лечению боли. Новые возможности: флупиртин: Список литературы

Список литературы

1. Баринов А.Н. Комплексное лечение боли // Рус. мед. журн. - 2007. - Т. 15, № 4. - С. 215–220
2. Вальдман А.В., Игнатов Ю.Д. Центральные механизмы боли. - Л.: Наука, 1976. - 191 с.
3. Вейн А.М. (ред.) Болевые синдромы в неврологической практике // М.: МЕДпресс-информ, 2001. - 372 с.
4. Вейн А.М., Авруцкий М.Я. Боль и обезболивание. - М.: Медицина, 1997. - 280 c.
5. Вейн А.М., Данилов А.Б. Проблема гендера в неврологии // Журн. неврол. и психиат. - 2003. - № 103(10). - С. 4–14.
6. Голубев В.Л. Боль - междисциплинарная проблема // Рус. мед. журн. - 2008. - Т. 16, спец. вып. - С. 37.
7. Грибова Н.П. Применение препарата Катадолон в лечении болевых синдромов при радикуломиелоишемии // Головная боль. - 2005. - № 9. - С. 12–15.
8. Данилов А.Б. Диагностика и лечение головной боли. Руководство для врачей общей практики и др. специальностей. - М., 2011. - С. 112.
9. Данилов А.Б., Давыдов О.С. Нейропатическая боль. М.: - «Боргес», 2007. - 198 с.
10. Данилов А.Б., Данилов Ал.Б. Боль: патогенез и лечение // Российский журнал боли. - 2010. - № 2. - С. 35–39.
11. Данилов Ал.Б. Возможности применения тизанидина (Сирдалуда) в клинической практике // Рус. мед. журн. - 2009. - Т. 17, № 20. - С. 1370–1376.
12. Исмагилов М.Ф. Головная боль напряжения. - Казань: Медицина, 2004. - 132 с.
13. Калюжный Л.В. Физиологические механизмы регуляции болевой чувствительности. - М.: Медицина, 1984. - 210 с.
14. Камчатнов П.Р., Батышева Т.Т., Ганжула П.А. и др. Применение Катадолона у больных со спондилогенной дорсалгией // Журн. неврол. и психиатр. - 2006. - Т. 106, № 11. - С. 46–49.
15. Каратеев А.Е., Яхно Н.Н., Лазебник Л.Б. и др. Применение нестероидных противовоспалительных препаратов. Клинические рекомендации. - М.: ИМАПРЕСС, 2009. - 167 с.
16. Крыжановский, Г.Н. Центральные механизмы патологической боли // Журн. неврологии и психиатрии им. С.С.Корсакова. - 1999. - № 99. - С. 4–7.
17. Кукушкин М.Л., Решетняк В.К. Механизмы возникновения острой боли и хронических болевых синдромов // Materia Medica. - 1997. - № 15. - С. 522.
18. Кукушкин М.Л., Хитров Н.К. Общая патология боли. - М.: Медицина, 2004. - 144 с.
19. Куцемилов И.Б. Клинико-эпидемиологическое исследование первичной головной боли взрослого населения г. Ростова-на-Дону: автореф. дис. канд. мед. наук. - М., 2005. - 24 с.
20. Левин Я.И., Стрыгин К.Н., Добровольская Л.Е. Катадолон в лечении боли в спине // Лечение нервных болезней. - 2005. - Т. 6, № 3. - С. 12–17.
21. Наприенко М.В., Филатова Е.Г. Применение Катадолона в лечении абузусной головной боли // Журн. неврол. и психиатр. - 2006. - Т. 106, № 10. - С. 38–41.
22. Орлова О.Р. Возможности и перспективы использования ботулотоксина в клинической практике // Рус. мед. журн. - 2006. - Т. 14, № 23. - С. 1700–1708.
23. Подчуфарова Е.В. Острая боль в пояснично-крестцовой области: обследование и лечение с позиций доказательной медицины // Рус. мед. журн. - 2007. - Т. 15, № 10. - С. 845–850.
24. Рыбак В.А., Карпова О.В. Эффективность применения Катадолона у больных с головной болью напряжения // Лекарственный вестник. - 2006. - № 6.
25. Эрдес Ш. Эффективность Катадолона (флупиртина) у пациентов с болями в нижней части спины // Врач. - 2007. - № 5. - С. 56–59.
26. Яхно Н.Н. Боль. Руководство для врачей и студентов. - М.: Медпресс, 2009. - 304 с.
27. Яхно Н.Н., Кукушкин М.Л., Давидов М.Л., Данилов А.Б., Амелин А. В., Куликов С. М. Результаты Российского эпидемиологического исследования распространенности невропатической боли, ее причин и характеристик в популяции амбулаторных больных, обратившихся к врачу-неврологу // Боль. - 2008. - № 3 (20).
28. Яхно Н.Н., Парфенов В.А., Алексеев В.В. Головная боль. - М.: Врач, 2000. - 150 с.
29. Bandura A., O'Leary A., Taylor С.В., Gauthier J., & Gossard D. Perceived self-efficacy and pain control: Opioid and nonopioid mechanisms // Journal of Personality and Social Psychology. - 1987. - S3. - P. 563–571.
30. Bandura A., Taylor С.В., Williams S.L., Mefford I., & Barchas J.D. Catecholamine secretion as a function of perceived coping selfefficacy // Journal of Consulting and Clinical Psychology. - 1985. - Vol. 53. - P. 406–414.
31. Barber Т. & Hahn K.W. Physiological and subjective responses to pain producing stimulation under hypnotically suggested and waking-imagined analgesia // Journal of Abnormal and Social Psychology. - 1962. - Vol. 65. - P. 411–418.
32. Bebenburg W. von, Thiel K., Engel J., Sheldrick W.S. Synthese und Molekulstruktur des konstitutionell neuartigen analgetikum Flupirtin // Chem. Z. - 1981. - Vol. 105. - P. 77–81.
33. Bendtsen L. Central sensitization in tension-type headache: possible pathophysiological mechanisms // Cephalalgia. - 2000. - Vol. 20. - P. 486–508.
34. Blanchard E.B. Long-term effects of behavioral treatment of chronic headache // Behavior Therapy. - 1987. - Vol. 18. - P. 375–385.
35. Blumer D. & Heilbronn M. Chronic pain as a variant of depressive disease // Journal of Nervous and Mental Disease. - 1982. - Vol. 170. - P. 381–406.
36. Carlsson K.H., Jurna I. Depression by flupirtine, a novel analgesic agent, of motor and sensory responses of the nociceptive system in the rat spinal cord // Eur. J. Pharmacol. - 1987. - Vol. 143(1). - P. 89–99.
37. Cassell E.J. The nature of suffering and the goals of medicine // New Engl.J.Med. - 1982. - Vol. 306. - P. 639–645.
38. Ciccone D.S. & Grzesiak R.С. Cognitive dimensions of chronic pain // Social Science and Medicine. - 1984. - Vol. 19. - P. 1339–1345.
39. Classification of chronic pain: descriptions of chronicpain syndromes and definitions of pain terms /prepared by International Association for the Study of Pain, Task Force on Taxonomy: editors, H. Merskey, N. Bogduk. - 2nd ed. Seattle: IASP Press, 1994. - 222 p.
40. Crombez G., Vervaet L., Lysens R., Baeyens F. & Eelen P. (1998). Avoidance and confrontation of painful, back-straining movements in chronic back pain patients // Behavior Modification. - 1998. - Vol. 22(1). - P. 62–78.
41. Crook J., Weir R., Tunks E. An epidemiologic follow-up survey of persistent pain sufferers in a group family practice and specialty pain clinic // Pain. - 1989. - Vol. 36. - P. 49–61.
42. Darius H., Shror K. The action of Flupirtine on prostaglandine formation and platekets agregation in vitro // Arzneimittelforschung. - 1985. - Vol. 35. - P. 55–59.
43. Desroches H.E, Kaiman B.D. & Ballard H.T. Factors influencing reporting of physical symptoms by aged patients // Geriatrics. - 1967. - Vol. 22. - P. 169–175.
44. Deyo R.A. The early diagnostic evaluation of patients with low back pain // Journal of General Internal Medicine. - 1986. - Vol. 1. - P. 328–338.
45. Deyo R.A., Walsh N.E., Martin D., Schoenfeld L.S. & Ramamurthy S. A controlled trial of transcutaneous electrical nerve stimulation (TENS) and exercise for chronic low back pain // New England Journal of Medicine. - 1990. - Vol. 322. - P. 1627–1634.
46. Dreiser R.L., Parc J.M., Velicitat P., Leu P.L. Oral meloxicam is effective in acute sciatica: two randomized double-blind trials versus placebo or diclofenac. Inflammation Res 2001; 50: Suppl 1: 17–23.
47. Dufton B.D. Cognitive failure and chronic pain // International Journal of Psychiatry in Medicine. -1989. - Vol. 19. - P. 291–297.
48. Dworkin S.E., & Massoth D.L. Temporomandibular disorders and chronic pain: Disease or illness // Journal of Prosthetic Dentistry. - 1994. - Vol. 7. - P. 29–38.
49. Engel George L. The need for a new medical model // Science. - 1977. - Vol. 196. - P. 129–136.
50. Engel J. Flupirtine - a new central acting analgesic with unique chemical structure // Postgrad. Med. - 1987. - Vol. 63, Supp. 3. - P. 15–17.
51. Ferrell B.A. Pain management in elderly people // J. Am. Geriatr. Soc. - 1991. - Vol. 39(1). - P. 64–73.
52. Fitzpatrick R.M., Hopkins A.P. & Harvard-Watts O. Social dimensions of healing: A longitudinal study of outcomes of medical management of headaches // Social Science and Medicine. - 1983. - Vol. 17. - P. 501–510.
53. Flor H., Schugens M.M., and Birbauer N. Discrimination of muscle tension in chronic pain patients and healthy controls // Biofeedback and Self-Regulation. - 1992. - Vol. 17(3). - P. 165–177.
54. Flor H., Turk D.C. & Birbaumer N. Assessment of stressrelated psychophysiological responses in chronic pain patients // Journal of Consulting and Clinical Psychology. - 1985. - Vol. 35. - P. 354–364.
55. Fordyce W.E., Roberts A.H. & Sternbach R.A. (1985). The behavioral management of chronic pain: A response to critics // Pain. - 1985. - Vol. 22. - P. 113–125.
56. Friedel H.A., Fitton A. Flupirtin. A review of its pharmacological properties, and therapeutic efficacy in pain states // Drugs. - 1993. - Vol. 45. - P. 548–569.
57. Galasko C.S., Courtenay P.M., Jane M., Stamp T.C. Trial of oral flupirtine maleate in the treatment of pain after orthopaedic surgery // Curr. Med. Res. Opin. - 1985. - Vol. 9(9). - P. 594–601.
58. Gassen M., Pergande G., Youdim В.H. Antioxidant properties of the triaminopyridine, flupirtine // Biochemical Pharmacology. - 1998. - Vol. 56(10). - P. 1323–1329.
59. Gloth F.M. Concerns with chronic analgesic therapy in elderly patients // Am. J. Med. - 1996. - Vol. 101(1A). - P. 19S–24S.
60. Greene С.S. & Laskin D.M. Long-term evaluation of conservative treatments for myofascial pain dysfunction syndrome // Journal of the American Dental Association. - 1974. - Vol. 89. - P. 1365–1368.
61. Gureje O., Simon G.E. & Van Korff M. A cross-national study of the course of persistent pain in primary care // Pain. - 2001. - Vol. 92. - P. 195–200.
62. Harrison R.F., Brennan M., Reed J.V., Wickham E.A. A review of post-episiotomy pain and its treatment // Curr. Med. Res. Opin. - 1987. - Vol. 10(6). - P. 359–363.
63. Herrmann W.M., Hiersemenzel R., Aigner M. et al. Long-term tolerability of Flupirtine // Fortschritte der Medizin. - 1993. - Vol. 111(15). - P. 313.
64. Hlavica P., Niebch G. Pharmacokinetics and biotransforma tion of the analgesic flupirtine in humans // Arzneimittelforschung. - 1985. - Vol. 35(1). - P. 67–74.
65. Jamner L.D. & Tursky B. Syndrome-specific descriptor profiling: A psychophysiological and psychophysical approach //Health Psychology. - 1987. - Vol. 6. - P. 417–430.
66. Jensen M.P., Romano J.M., Turner J.A., Good A.B. & Wald L.H. Patient beliefs predict patient functioning: Further support for a cognitive-behavioural model of chronic pain // Pain. - 1999. - Vol. 81. - P. 95–104.
67. Jensen M.P., Turner J.A., Romano J.M. Self-efficacy and outcome expectancies: relationship to chronic pain coping strategies and adjustment // Pain. - 1991. - Vol. 44. - P. 263–269.
68. Kornhuber J., Bleich S., Wiltfang J. et al. Flupirtine shows functional NMDA receptor antagonism by enhancing Mg2+ block via activation of voltage independent potassium channels // J. Neural. Transm. - 1999. - Vol. 106(910). - P. 857–867.
69. Knost В., Flor H., Braun C. & Birbaumer N. Cerebral processing of words and the development of chronic pain // Psychophysiology. - 1997. - Vol. 34. - P. 474–481.
70. Lawson K., Reesor K.A., Keefe E.J., Turner J.A. Dimensions of pain-related cognitive coping: Cross validation of the factor structure of the Coping Strategies Questionnaire // Pain. - 1990. - Vol. 43. - P. 195–204.
71. Lefebvre M.F. Cognitive distortion and cognitive errors in depressed psychiatric and low back pain patients // Journal of Consulting and Clinical Psychology. - 1981. - Vol. 49. - P. 517.
72. Lüben V., Müller H., Lobisch M., W rz R. Treatment of tumor pain with flupirtine. Results of a double-blind study versus tramadol // Fortschr. Med. - 1994. - Vol. 112(19). - P. 282–286.
73. Lynch D. Geriatric Pain // Curr. Rev. Pain. - 1999. - Vol. 3(5). - P. 388–399.
74. Lyngberg A.C., Rasmussen B.K., Jorgensen T., Jensen R. Has the prevalence of migraine and tension-type headache changed over a 12-year period? A Danish population survey // Eur. J. Epidemiol. - 2005. - Vol. 20(3). - P. 243–249.
75. Mantyselka P., Kumpusalo E., Ahonen R. et al. Pain as a reason to visit the doctor: a study in Finnish primary health care // Pain. - 2001. - Vol. 89. - P. 175–180.
76. Mastronardi P., D'Onofrio M., Scanni E. et al. Analgesic activity of flupirtine maleate: a controlled double-blind study with diclofenac sodium in orthopaedics // J. Int. Med. Res. - 1988. - Vol. 16(5). - P. 338–348.
77. Mazzarella B., Ceccarelli M.G. & Bianchi F. Analgesic activity of flupirtine maleate // J. Int. Med. Res. - 1988. - Vol. 16. - P. 338–348.
78. McCracken L.M., Gross R.T. The role of pain-related anxiety reduction in the outcome of multidisciplinary treatment for chronic low back pain: preliminary results // J.Occ.Rehab. - 1998. - Vol. 8. - P. 3.
79. McCracken L.M., Gross R.Т., Sorg P.J., Edmands T.A. Prediction of pain in patients with chronic low back pain: Effects of inaccurate prediction and pain-related anxiety // Behavior Research and Therapy. - 1993. - Vol. 31. - P. 647–652.
80. McMahon G., Arndt W., Newton J., Montgomery P. Clinical experience of flupirtine in the US // Postgrad. Med. J. - 1987. - Vol. 63. - P. 81–85.
81. Mechanic D. The concept of illness behavior // Journal of Chronic Disease. - 1962. - Vol. 15. - P. 189–194.
82. Mechanic D. Illness behavior: An overview / In S. McHugh & Т.М. Vallis (Eds.), Illness behavior: A multidisciplinary model (pp. 101–110). New York: Plenum Press, 1986.
83. Melzack R. Pain and stress: A new perspective / In R.J. Gatchel & D.С. Turk (Eds.), Psychosocial factors in pain: Critical perspectives (pp. 89–106). New York: Guilford Press, 1999.
84. Melzack R. & Casey K.L. Sensory, motivational and central control determinants of pain: A new conceptual model / In D. Kenshalo (Ed.), The skin senses (pp. 423–443). Springfield, IL: Thomas, 1968.
85. Million R., Finlay B.R., Whittington J.R. Clinical trial of flupirtine maleate in patients with migraine // Curr. Med. Res. Opin. - 1984. - Vol. 9(3). - P. 204–212.
86. Mizener D., Thomas M., Billings R. Cognitive changes of migraineurs receiving biofeedback training // Headache. - 1988. Vol. 28. - P. 339–343.
87. Moore R.A., Bullingham R.E., Simpson S. et al. Comparison of flupirtine maleate and dihydrocodeine in patients following surgery // Br. J. Anaesth. - 1983. - Vol. 55(5). - P. 429–432.
88. Mueller-Schwefe G. Flupirtine in Acute and Chronic Pain Associated with Muscle Tenseness. Results of a Postmarketing Surveillance Study // Fortschr. Med. - 2003. - Vol. 121. - P. 310.
89. Okifuji A., Turk D.C. & Curran S.L. Anger in chronic pain: investigations of anger targets and intensity // J. Psychosom. - 1999. - Res 47. - P. 1–12.
90. Okifuji A., Turk D.C. & Sherman J.J. (2000): Evaluation of the relationship between depression and fibromyalgia syndrome: why aren't all patients depressed? // J Rheumatol. - 2000. - Vol. 27. - P. 212–219.
91. Parsons T. Definitions of health and illness in the light of American values and social structure / In E.G. Jaco (Ed.), Patients, physicians, and illness (pp. 3–29). 1958.
92. Perovic S., Pialoglou P., Schroder H.C. et al. Flupirtine increases the levels of glutathione and Bc1-2 in hNT (human Ntera/D1) neurons: mode of action of the drug-mediated anti-apoptotic effect // Eur. J. Pharmacol. - 1996. - Vol. 317(1). - P. 157–164.
93. Perovic S., Schleger C., Pergande G. et al. The triaminopyridine flupirtine prevents cell death in rat cortical cells induced by NMDA and gpl20 // Eur. J. Pharmacol. - Mol. Pharmacol. Sect. - 1994. - Vol. 288. - P. 27–33.
94. Richard K. The occurrence of maladaptive health-related behaviors and teacher-related conduct problems in children of chronic low back pain patients//Journal of Behavioral Medicine. - 1988. - Vol. 11. - P. 107–116.
95. Riethmüller-Winzen H. Flupirtine in the treatment of postoperative pain // Postgrad. Med. J. - 1987. - Vol. 63, Suppl. 3. - P. 61–65.
96. Rimm D.C., & Litvak S.B. Self-verbalizations and emotional arousal // Journal of Abnormal Psychology. - 1969. - Vol. 74. - P. 181–187.
97. Ringe J.D., Miethe D., Pittrow D., Wegscheider K. Аnalgesic efficacy of flupirtine in primary care of patients with osteoporosis related pain. A multivariate analysis // Arzneimittelforschung. - 2003. - Vol. 53(7). - P. 496–502.
98. Romano J.M., Turner J.A. Chronic pain and depression: does the evidence support a relationship? // Psychol Bull. - 1985. - Vol. 97. - P. 18–34.
99. Ruppala K., Cao W., Kriegelstein J. Flupirtine protects neurones against ischemic and excitotoxic damage and inhibits the increase ocytosolic Ca2+ concentration // Eur. J. Pharmacol. - 1995. - Vol. 294. - P. 469–473.
100. Russell M.B. Tension-type headache in 40-year-olds: a Danish population-based sample of 4000 // J. Head. Pain. - 2005. - Vol. 6(6). - P. 441–447.
101. Schwartz B.S., Stewart W.F., Simon D., Lipton R.B. Epidemiology of tension-type headache // J. A. M. A. - 1998. - Vol. 279(4). - P. 381–383.
102. Sitzer G. Einfachblindstudie mit Flupirtine gagan Acetylsalicylsaure bei Patienten mit Spinalem Wurzelreizsyndrome // Orthop. Traumatol. - 1991. - Vol. 6. - P. 37–44.
103. Smith T.W., Aberger E.W., Follick M.J., & Ahern D.K. Cognitive distortion and psychological distress in chronic lowback pain // Journal of Consulting and Clinical Psychology. - 1986. - Vol. 54. - P. 573–575.
104. Sorkin B.A., Rudy T.E. et al. Chronic pain in old and young patients: differences appear less important than similarities // J. Gerontol. - 1990. - Vol. 45(2). - P. 64–68.
105. Stoll A.L., M.D., Belmont, MA. Fibromyalgia Symptoms Relieved by Flupirtine: An Open-Label Case Series // Psychosomatics. - 2000. - Vol. 8(41). - P. 371–372.
106. Summers J.D., Rapoff M.A., Varghese G. et al. Psychological factors in chronic spinal cord injur pain // Pain. - 1992. - Vol. 47. - P. 183–189.
107. Szelenyi I., Nickel B., Borbe H.O., Brune H. Mode of antinociceptive action on flupirtine in the rats // Br. J. Pharmacol. - 1989. - Vol. 97. - P. 835–842.
108. Turk D.C., Meichenbaum D. & Genest M. Pain and behavioral medicine: A cognitive-behavioral perspective. New York: Guilford Press, 1983.
109. Turk D.C., & Okifuji A. Evaluating the role of physical, operant, cognitive, and affective factors in the pain behaviors of chronic pain patients // Behav Modif. - 1997. - Vol. 21. - P. 259–280.
110. Turk, D.C. & Okifuji, A. A cognitive-behavioral approach to pain management / In: Textbook of Pain, eds. P. Wall & R. Melzack, 1999, pp. 1431–1444: Churchill Livingstone.
111. Turk D.C., Rudy Т.Е. Toward an empirically derived taxonomy of chronic pain patients: Integration of psychological assessment data // Journal of Consulting and Clinical Psychology. с1988. - Vol. 56. - P. 233–238.
112. Turk D.C. & Salovey P. Chronic pain as a variant of depressive disease: A critical reappraisal // The Journal of Nervous and Mental Disease. - 1984. - Vol. 172. - P. 398–404.
113. Turner J., Deyo R.A., Loeser J.D., Von Korff M. & Fordyce W.E. The importance of placebo effects in pain treatment and research // Journal of the American Medical Association. - 1994. - Vol. 271. - P. 609–1614.
114. Vandenheede M., Schoenen J. Central mechanisms in tension-type headaches // Curr. Pain Head. Rep. - 2002. - Vol. 6, N 5. - P. 392–400.
115. Weiser T., Szelenyi I., Nickel B., Weinrich M. In vitro and in vivo findings about the muscle relaxing properties of flupirine // Naunyn-Schmiedeberg’s Arch. Pharmacol. - 1992. - Vol. 246, Supp. 1. - P. R22.
116. White K.L., Williams F. & Greenberg B.G. The ecology of medical care // New England Journal of Medicine. - 1961. - Vol. 265. - P. 885–886.
117. Williams D.A., Keefe F.J. Pain beliefs and the use of cognitivebehavioral coping strategies // Pain. - 1991. - Vol. 46. - P. 185–190.
118. Wolff H.G. Headache and other head pain. New York: Oxford Univ. Press, 1963.
119. Wörz R. Flupirtine in chronic myofacial pain conditions // Fortschr. Med. - 1991. - Vol. 109(6). - P. 158–160.
120. Wörz R. Long-term treatment with flupirtine. 7 years continuous therapy of a chronic pain syndrome // Schmerz. - 2000. - Vol. 14(1). - P. 29–32.
121. Wörz R., Lobisch M., Schwittmann B. et al. Effectiveness of flupirtine in chronic tension headache. Results of a double-blind study versus placebo // Fortschr. Med. - 1995. - Vol. 113(32). - P. 463–468.
122. Wörz R., Mueller-Schwefe G., Stroehmann I. et al. Back pain: Guidelines for drug therapy // Fortschr. Med. - 2000. - Vol. 142(5). - P. 27–33.
123. Wörz R. et al. Flupirtine in comparison with ehlomiezanone in chronic musculoskeletal back pain. Results of a multicenter randomized double-blind study // Fortschr. Med. - 1996. - Vol. 114(3536). - P. 500–504.

Назад | Оглавление

Комментарии